Wegovy 7.2mg: the higher dose and what it means for you

What actually changed when 7.2mg was approved

For several years, 2.4mg was the ceiling for Wegovy in weight management. The MHRA's approval in January 2026 changed that. The first route to 7.2mg was three separate 2.4mg pens taken weekly; then, in April 2026, a purpose-built single-dose pen was approved, delivering the full 7.2mg in one weekly injection with the same auto-dosing mechanism and covered needle already familiar from the lower-strength pens. The dedicated pen is the version most people will encounter going forward. For a detailed look at the regulatory timeline, the MHRA's approval process for the 7.2mg dose is covered separately.

The approval was supported by trial data showing around 20.7% average weight loss at 72 weeks, which pulls Wegovy meaningfully closer to tirzepatide's results at its highest dose than the 2.4mg data alone ever did. The MHRA's announcement of the single-dose 7.2mg pen sets out the basis for approval in plain terms.

One thing that did not change: the starting point. Whether someone ends up at 2.4mg or 7.2mg, every Wegovy journey begins at 0.25mg. That first low dose is there to let your body adjust to the medicine before the prescriber steps the dose upward, roughly monthly. Seven months at minimum separates the first injection from the maximum dose.

Who the 7.2mg dose is actually licensed for

The licence is specific. The 7.2mg dose of Wegovy is for adults with a BMI of 30 or above, used alongside a reduced-calorie diet and increased physical activity. It is not licensed for people with a BMI below 30, even where a lower Wegovy dose might be appropriate for a weight-related condition. It is also not the dose used for the separate cardiovascular risk indication. Those boundaries come from the MHRA, not from individual clinician preference.

In practice, reaching 7.2mg requires that a prescriber judges the dose clinically appropriate for you at that stage of treatment. Response to earlier doses, side-effect tolerability, and whether you are still making meaningful progress all feed into that review. It is not automatic progression.

For context on how the dose fits within Wegovy's full schedule, the complete Wegovy dosing ladder explains where each strength sits and why the titration exists. And if you are weighing Wegovy against other options, an overview of licensed weight-loss treatments in the UK lays out what is currently available.

What the 7.2mg pen physically is

The dedicated single-dose pen is pre-set. You cannot dial a dose or make an error with the strength; it delivers 7.2mg and locks after use. The covered needle engages automatically on injection, which many people find more comfortable than pens they had used before. Storage follows the same refrigeration requirement as other Wegovy pens: 2–8°C until you use it, with a limited window at room temperature described in the Patient Information Leaflet. Always follow the leaflet rather than any general guidance on this point, since the window matters for potency.

If you order through a regulated online pharmacy like nume, the pen arrives the next working day via DPD in plain, unbranded packaging, with a tracking notification to your phone. Nothing about the box signals what's inside.

People's experience at this dose varies. For a grounded picture of what patients report, real-world feedback on the 7.2mg dose is worth reading alongside the clinical data. Side effects at this strength are covered in detail on the 7.2mg Wegovy side effects page, and the NHS semaglutide medicines page lists the full safety profile.

Cost and access at this dose

The 7.2mg dose is not available on the NHS. NICE has not appraised it, and until a formal appraisal concludes, NHS commissioning for semaglutide at this strength is not in place. That may change, but there is no confirmed timetable.

Private prescription is currently the only route. Prices for the 7.2mg pen sit at the higher end of the Wegovy cost range because of the dose, and the overall private market for Wegovy in the UK has seen price movement since Eli Lilly's list-price increase in September 2025 affected the broader weight-loss injection market. For current pricing context, Wegovy pricing in the UK breaks down what is typically included and what to watch for when comparing providers.

Availability at this specific strength is worth confirming before you commit to a consultation. Current 7.2mg Wegovy availability in the UK tracks stock position as it stands. If you want to understand what the full Wegovy picture looks like, the Wegovy treatment overview covers everything from mechanism to eligibility in one place. When you are ready to talk through whether this dose makes sense for you, starting a free consultation puts your case in front of a real prescriber the same day.